Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Meidi Utami Puteri

11PUBLICATIONS

12CO-AUTHORS

Predictive and prognostic markersCellular interactions (incl. adhesion, matrix, cell wall)Traditional Chinese medicine and treatmentsExercise physiologyCheminformatics and quantitative structure-activity relationships

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (11)

Sort by Publication Date:

|Jan 28, 2026

PCSK9 in Cancer: Biological Mechanisms and Implications for Therapeutic Resistance.

Nuriza Ulul Azmi, Rezi Riadhi Syahdi, Meidi Utami Puteri

|Dec 30, 2025

The Roles of PCSK9 in Alzheimer's Disease: A Systematic Review of Clinical, Genetic, and Preclinical Evidence.

Vicko Suswidiantoro, Meidi Utami Puteri, Mitsuyasu Kato

|Dec 30, 2024

Antiplatelet Effects of a Combination of Sappan Wood (<i>Caesalpinia sappan</i> L.) and Red Ginger (<i>Zingiber officinale var. Rubrum</i>) Extracts in a High-Fat Diet-Induced Rat Model.

Meidi Utami Puteri, Nur Afifah, Anisa Qisti Mathriul

|Oct 28, 2023

High-Fat Diet Enhances Platelet Activation and Is Associated with Proprotein Convertase Subtilisin Kexin 9: An Animal Study.

Fadlina Chany Saputri, Nuriza Ulul Azmi, Meidi Utami Puteri

|Oct 20, 2023

Brazilin from <i>Caesalpinia sappan</i> L. as a Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitor: Pharmacophore-Based Virtual Screening, <i>In Silico</i> Molecular Docking, and <i>In Vitro</i> Studies.

Muhammad Iqbal, Nur Hasanah, Aimee Detria Arianto

|Jul 29, 2023

Platelet Glycoprotein-Ib (GPIb) May Serve as a Bridge between Type 2 Diabetes Mellitus (T2DM) and Atherosclerosis, Making It a Potential Target for Antiplatelet Agents in T2DM Patients.

Muttia Amalia, Meidi Utami Puteri, Fadlina Chany Saputri

Pageof 2

Frequent Collaborators

8 joint publications

Fadlina Chany Saputri

7 joint publications

Mitsuyasu Kato

1 joint publications

Yukihide Watanabe

1 joint publications

Bantari Wk Wardhani

1 joint publications

Melva Louisa

1 joint publications

Md Anwarul Haque

1 joint publications

Vicko Suswidiantoro

1 joint publications

Donna Maretta Ariestanti

1 joint publications

Richard Johari James

1 joint publications

Nuriza Ulul Azmi

Frequent Collaborators

8 joint publications

Fadlina Chany Saputri

7 joint publications

Mitsuyasu Kato

1 joint publications

Yukihide Watanabe

1 joint publications

Bantari Wk Wardhani

Top Related Videos

A High-Throughput Luciferase Assay to Evaluate Proteolysis of the Single-Turnover Protease PCSK9

A High-Throughput Luciferase Assay to Evaluate Proteolysis of the Single-Turnover Protease PCSK9

Published on : Aug 28, 2018

Turbidimetry on Human Washed Platelets: The Effect of the Pannexin1-inhibitor Brilliant Blue FCF on Collagen-induced Aggregation

Turbidimetry on Human Washed Platelets: The Effect of the Pannexin1-inhibitor Brilliant Blue FCF on Collagen-induced Aggregation

Published on : Apr 06, 2017

See more related videos

Top Related Videos

A High-Throughput Luciferase Assay to Evaluate Proteolysis of the Single-Turnover Protease PCSK9

A High-Throughput Luciferase Assay to Evaluate Proteolysis of the Single-Turnover Protease PCSK9

Published on : Aug 28, 2018

Turbidimetry on Human Washed Platelets: The Effect of the Pannexin1-inhibitor Brilliant Blue FCF on Collagen-induced Aggregation

Turbidimetry on Human Washed Platelets: The Effect of the Pannexin1-inhibitor Brilliant Blue FCF on Collagen-induced Aggregation

Published on : Apr 06, 2017

See more related videos